数量接近去年全年 上半年我国批准创新药43个 涉及罕见病、肿瘤等

Core Insights - The National Medical Products Administration (NMPA) approved 43 innovative drugs in the first half of the year, representing a 59% year-on-year increase, nearing the total of 48 drugs approved in 2024 [1] Group 1: Drug Approvals - The approved drugs include treatments for major diseases such as cancer, metabolic disorders, and immune diseases [1] - Notably, the first domestic gene therapy product for Hemophilia B was approved, along with a drug for a rare immune metabolic disease [1]